tirzepatide 20mg vial Tirzepatide, Dual GLP-1 and GIP Research Peptide Tirzepatide 60mg/3mL (20mg/mL) | Pipeline

Most researchers prefer the first option for simplicity

The Delhi High Court has opened the door for Sun Pharma to manufacture and export semaglutidebased weightloss drugs to countries where Novo Nordisk does not hold a valid patent, but has kept a firm pause on sales in India until the secondary patent runs out in March 2026

The drug is now also available through U.S

Additional TRIUMPH and Other Phase 3 Trials Lilly has initiated or announced additional Phase 3 trials for retatrutide: Chronic low back pain -- Phase 3 initiated in Q3 2025 Overweight/obesity (additional) -- new Phase 3 trial initiated in Q3 2025 MASLD master protocol (NCT07165028) -- a Phase 3 multi-agent master protocol in MASLD that includes retatrutide (not a dedicated retatrutide-only liver trial), building on the Phase 2 liver fat sub-study TRANSCEND Program -- Type 2 Diabetes TRANSCEND Phase 3 program evaluating retatrutide specifically for type 2 diabetes

If you've been Googling "is tirzepatide a peptide" at midnight, you're probably looking for something that actually works